Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Cardium Therapeutics, Inc. (CXM) Enters Distribution Agreement Targeting Governmental Medical Facilities

|Includes: Cardium Therapeutics, Inc (CXM)

Today before the open, Cardium Therapeutics announced that it has signed a distribution agreement with AvKARE encompassing government medical facilities throughout the United States. The new commercialization arrangement with AvKARE effectively replaces an earlier arrangement with Academy Medical.

Cardium chose to transfer the Excellagen distribution responsibilities to AvKARE, a licensed manufacturer/wholesaler of pharmaceuticals, disposable medical supplies, and capital medical equipment. The officers and management team at AvKARE have more than 80 years' experience in the pharmaceutical and medical supply industry.

As part of the agreement, AvKARE provides five direct wound care experts and allows Cardium's 25 distributor representatives access to all government accounts. The company serves the Department of Defense, Veterans Hospitals, NASA, TriCare, Dept. of Agriculture, Indian Health Services, USDA, U.S. Army, Air Force, Navy, and USMC, as well as Group Purchasing Organizations that include Amerinet, Innovatix, Health Trust Purchasing Group, IPC, Broadlane/MedAssets and Premier.

To learn more about AvKARE, visit Excellagen.com/AvKARE

To learn more about Cardium, visit CardiumTHX.com

Please see disclaimer on the MissionIR website

www.missionir.com/disclaimer.html